When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADAP - Adaptimmune up 3% premarket on SPEAR T-cell development deal
Adaptimmune Therapeutics plc
Adaptimmune (NASDAQ:ADAP) inks an agreement with Tokyo-based Noile-Immune Biotech to co-develop next-generation SPEAR T-cell products incorporating the latter's PRIME (proliferation-inducing and migration-enhancing) technology to augment CAR-T cell activity.
More news on: Adaptimmune Therapeutics plc, Healthcare stocks news, Stocks on the move,